IL1B and cardiovascular disorder: Furthermore, it is not clear whether the upregulated miR-155 is correlated with the dysregulated release of CKs, especially TNF-α and IL-1β, which cause synovial inflammation, systemic effects and cardiovascular disease [2,3].